Birdwatch Note
2023-08-12 15:56:46 UTC - NOT_MISLEADING
Since March 2021 there have been reports from the UK and internationally of an extremely rare condition characterised by thromboembolic events (blood clots) accompanied by thrombocytopenia (low platelets) following the first dose of the AstraZeneca (AZ) COVID-19 vaccination. https://www.publichealth.hscni.net/sites/default/files/2021-07/COVID-19_V4_AZ_factsheet_9pp_A4_11_07_21_final.pdf
Written by 062F26DEE3C020DA0013D89EFB7D7488BA56A66E7715A815F2053A7B670C615F
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1690054601892864011
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1690391888497397882
- noteId - 1690391888497397882
- participantId -
- noteAuthorParticipantId - 062F26DEE3C020DA0013D89EFB7D7488BA56A66E7715A815F2053A7B670C615F Participant Details
- createdAtMillis - 1691855806838
- tweetId - 1690054601892864011
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Since March 2021 there have been reports from the UK and internationally of an extremely rare condition characterised by thromboembolic events (blood clots) accompanied by thrombocytopenia (low platelets) following the first dose of the AstraZeneca (AZ) COVID-19 vaccination. https://www.publichealth.hscni.net/sites/default/files/2021-07/COVID-19_V4_AZ_factsheet_9pp_A4_11_07_21_final.pdf
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-08-12 15:56:46 UTC (1691855806838) |
1969-12-31 23:59:59 UTC (-1) |
2023-08-14 02:09:58 UTC (1691978998272) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-08-13 17:02:19 -0500 | Rating Details | |
| 2023-08-13 08:32:31 -0500 | Rating Details | |
| 2023-08-13 08:29:11 -0500 | Rating Details | |
| 2023-08-13 07:51:15 -0500 | Rating Details | |
| 2023-08-13 07:33:12 -0500 | Rating Details | |
| 2023-08-13 07:13:40 -0500 | Rating Details | |
| 2023-08-13 03:41:52 -0500 | Rating Details | |
| 2023-08-13 03:37:33 -0500 | Rating Details | |
| 2023-08-13 03:15:06 -0500 | Rating Details | |
| 2023-08-13 03:11:22 -0500 | Rating Details | |
| 2023-08-13 00:31:10 -0500 | Rating Details | |
| 2023-08-12 22:55:03 -0500 | Rating Details | |
| 2023-08-12 20:08:44 -0500 | Rating Details | |
| 2023-08-12 16:14:50 -0500 | Rating Details | |
| 2023-08-12 15:42:25 -0500 | Rating Details | |
| 2023-08-12 15:06:03 -0500 | Rating Details | |
| 2023-08-12 14:53:26 -0500 | Rating Details | |
| 2023-08-12 14:40:38 -0500 | Rating Details | |
| 2023-08-12 13:53:30 -0500 | Rating Details | |
| 2023-08-12 13:32:56 -0500 | Rating Details | |
| 2023-08-12 13:24:03 -0500 | Rating Details | |
| 2023-08-12 12:41:13 -0500 | Rating Details | |
| 2023-08-12 12:38:27 -0500 | Rating Details | |
| 2023-08-12 12:36:32 -0500 | Rating Details | |
| 2023-08-12 12:03:08 -0500 | Rating Details | |
| 2023-08-12 11:41:59 -0500 | Rating Details | |
| 2023-08-12 11:31:59 -0500 | Rating Details | |
| 2023-08-12 11:10:03 -0500 | Rating Details | |
| 2023-08-15 03:27:04 -0500 | Rating Details | |
| 2023-08-17 10:17:42 -0500 | Rating Details | |
| 2023-08-19 00:27:10 -0500 | Rating Details | |
| 2023-08-18 02:08:18 -0500 | Rating Details | |
| 2023-08-13 15:04:36 -0500 | Rating Details | |
| 2023-08-13 05:52:59 -0500 | Rating Details | |
| 2023-08-12 19:33:01 -0500 | Rating Details | |
| 2023-08-12 18:09:19 -0500 | Rating Details | |
| 2023-08-12 18:04:00 -0500 | Rating Details | |
| 2023-08-12 12:23:26 -0500 | Rating Details | |
| 2023-09-03 00:24:22 -0500 | Rating Details | |
| 2023-09-10 15:01:36 -0500 | Rating Details | |
| 2023-09-10 14:37:07 -0500 | Rating Details | |
| 2023-09-10 13:58:50 -0500 | Rating Details | |
| 2023-09-23 09:52:53 -0500 | Rating Details | |
| 2023-11-09 14:48:37 -0600 | Rating Details | |
| 2023-12-06 07:31:31 -0600 | Rating Details | |
| 2023-12-11 12:23:14 -0600 | Rating Details | |
| 2023-12-11 11:31:20 -0600 | Rating Details | |
| 2023-12-24 13:04:31 -0600 | Rating Details | |
| 2024-01-08 05:04:45 -0600 | Rating Details | |
| 2024-01-28 15:52:06 -0600 | Rating Details | |
| 2024-01-28 07:06:34 -0600 | Rating Details | |
| 2024-02-06 00:37:43 -0600 | Rating Details | |
| 2024-02-05 09:21:58 -0600 | Rating Details | |
| 2024-02-06 01:42:27 -0600 | Rating Details | |
| 2024-02-19 14:25:27 -0600 | Rating Details | |
| 2024-02-19 14:03:39 -0600 | Rating Details | |
| 2024-02-19 07:26:54 -0600 | Rating Details | |
| 2024-02-19 05:57:41 -0600 | Rating Details | |
| 2024-02-20 17:16:13 -0600 | Rating Details | |
| 2024-02-20 05:46:10 -0600 | Rating Details | |
| 2024-02-20 01:43:34 -0600 | Rating Details | |
| 2024-02-19 00:40:58 -0600 | Rating Details | |
| 2024-02-18 21:08:14 -0600 | Rating Details | |
| 2024-03-04 03:18:24 -0600 | Rating Details | |
| 2024-02-23 06:02:39 -0600 | Rating Details | |
| 2024-04-13 08:51:04 -0500 | Rating Details | |
| 2024-04-24 05:34:21 -0500 | Rating Details | |
| 2024-05-02 07:08:05 -0500 | Rating Details | |
| 2024-06-09 04:54:34 -0500 | Rating Details | |
| 2024-09-08 07:26:43 -0500 | Rating Details | |
| 2024-09-08 01:01:47 -0500 | Rating Details | |
| 2024-09-07 18:50:49 -0500 | Rating Details |